We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

104 hedge funds and large institutions have $135M invested in Pernix Therapeutics Holdings, Inc. in 2015 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

24% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 34

9% less funds holding

Funds holding: 114104 (-10)

35% less capital invested

Capital invested by funds: $209M → $135M (-$73.1M)

42% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 24

95% less call options, than puts

Call options by funds: $24K | Put options by funds: $506K

Holders
104
Holders Change
-10
Holders Change %
-8.77%
% of All Funds
2.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
14
Increased
42
Reduced
34
Closed
24
Calls
$24K
Puts
$506K
Net Calls
-$482K
Net Calls Change
+$106K
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
$154K -$163K -3,411 -41%
EGA
52
Eagle Global Advisors
Texas
$154K +$51.5K +1,076 +28%
AllianceBernstein
53
AllianceBernstein
Tennessee
$150K
Group One Trading
54
Group One Trading
Illinois
$143K -$14.4K -300 -6%
BG
55
BlackRock Group
United Kingdom
$133K +$202K +4,224 New
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$125K -$8.37K -175 -4%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$118K +$7.27K +152 +4%
Balyasny Asset Management
58
Balyasny Asset Management
Illinois
$116K +$176K +3,680 New
Goldman Sachs
59
Goldman Sachs
New York
$115K -$54.6K -1,141 -24%
Citadel Advisors
60
Citadel Advisors
Florida
$99K -$1.35M -28,209 -90%
D.E. Shaw & Co
61
D.E. Shaw & Co
New York
$99K +$100K +2,094 +203%
DekaBank Deutsche Girozentrale
62
DekaBank Deutsche Girozentrale
Germany
$96K +$45.4K +950 +45%
NFA
63
Nationwide Fund Advisors
Ohio
$89K -$974K -20,350 -88%
MLICM
64
Metropolitan Life Insurance Company (MetLife)
New York
$89K +$12.7K +266 +10%
PPA
65
Parametric Portfolio Associates
Washington
$89K +$20.1K +421 +18%
SG Americas Securities
66
SG Americas Securities
New York
$88K +$133K +2,776 New
HCMT
67
Highland Capital Management (Tennessee)
Tennessee
$82K +$23.9K +500 +24%
AIG
68
American International Group
New York
$81K +$144 +3 +0.1%
California Public Employees Retirement System
69
California Public Employees Retirement System
California
$78K -$139K -2,900 -54%
VOYA Investment Management
70
VOYA Investment Management
Georgia
$76K
OC
71
Oppenheimer & Co
New York
$76K +$16.7K +350 +17%
Wells Fargo
72
Wells Fargo
California
$74K -$2.61M -54,655 -96%
DTL
73
Dynamic Technology Lab
Singapore
$74K +$112K +2,335 New
TDC
74
Thompson Davis & Co
Virginia
$72K -$46.6K -975 -30%
DLG
75
Daniel L. Goodwin
$72K

PTX Hedge Fund Activity: Q3 2015 in Review

104 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q3 2015, worth a combined $135M — down 35% from $209M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PTX and 14 opened new positions — a net loss of 10 holders — while 34 trimmed existing stakes and 42 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $23M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $14.8M sold.

  • 104 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q3 2015, down from 114 in Q2 2015.
  • Funds reported $135M of Pernix Therapeutics Holdings, Inc. stock for Q3 2015, down 35% quarter-over-quarter.
  • 14 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q3 2015 and 24 closed out, a net change of -10 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q3 2015 was Armistice Capital, an estimated $23M added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q3 2015 was Janus Henderson Investors US, an estimated $14.8M sold.

Based on aggregated 13F filings for Q3 2015.